Multiple primary cancers as a guide to heritability

scientific article

Multiple primary cancers as a guide to heritability is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/IJC.28988
P698PubMed publication ID24945890

P50authorSteven A. NarodQ50384888
Cezary CybulskiQ42590472
P2093author name stringSafia Nazarali
P2860cites workLinkage of ATM to cell cycle regulation by the Chk2 protein kinaseQ22008502
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeQ22011001
Mutations of two PMS homologues in hereditary nonpolyposis colon cancerQ24318484
von Hippel-Lindau disease: a clinical and scientific reviewQ24622030
Meta-analysis of BRCA1 and BRCA2 penetranceQ24654786
Will the real Cowden syndrome please stand up: revised diagnostic criteriaQ24681567
The pathology of familial breast cancer: Morphological aspectsQ24800393
Mutation of a mutL homolog in hereditary colon cancerQ28114939
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1Q28115843
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2Q28212276
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYHQ28212369
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsQ28215462
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancerQ28257360
Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancerQ28260081
Colorectal cancer due to deficiency in DNA mismatch repair function: a reviewQ28262308
Cancer genes and the pathways they controlQ28275089
Identification of the breast cancer susceptibility gene BRCA2Q29616290
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasmsQ29618586
Identification of the von Hippel-Lindau disease tumor suppressor geneQ29618644
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumQ29619206
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsQ29619407
Realizing the promise of cancer predisposition genesQ30743260
Von Hippel-Lindau disease: a genetic studyQ33597245
Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancersQ33795280
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotypeQ33904762
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer geneticsQ34015399
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomasQ34020549
Germline p16 mutations in familial melanomaQ34059915
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?Q34232464
BRCA1-positive breast cancers in young women from Poland.Q44949616
Multiple primary cancers in families with Li-Fraumeni syndromeQ44955059
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer familiesQ45243999
The risk of gastric cancer in carriers of CHEK2 mutationsQ45259012
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutationsQ47645440
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndromeQ47762736
The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer.Q50601473
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.Q50680047
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.Q51421155
Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.Q54441713
Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP).Q54441823
A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor GeneQ55670980
Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma FamiliesQ56436681
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMELQ56437244
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility GeneQ56438525
Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutationQ56456411
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsQ57250780
Is CHEK2 a cause of the Li Fraumeni syndrome?Q57266694
Risk of Cancer in Relatives of Prostate Cancer ProbandsQ57307341
Clinical Implications of the Colorectal Cancer Risk Associated With MUTYH MutationQ57319696
Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implicationsQ59238491
Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis RegisterQ34252458
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer familiesQ34387715
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupQ34512590
LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.Q34540867
A high proportion of founder BRCA1 mutations in Polish breast cancer familiesQ34548008
CHEK2 is a multiorgan cancer susceptibility geneQ34551970
Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?Q34572576
E-cadherin germline mutations in familial gastric cancer.Q34746744
Pancreatic carcinoma surveillance in patients with familial melanomaQ35202340
Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.Q35357970
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterationsQ35597950
Site-specific familial aggregation of prostate cancer.Q35678492
Lifetime cancer risks in individuals with germline PTEN mutations.Q35681689
The risk of breast cancer in women with a BRCA1 mutation from North America and PolandQ35907001
The genetics of FAP and FAP-like syndromesQ36602699
CHEK2 variants associate with hereditary prostate cancerQ36671622
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsQ36824964
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotypeQ37147694
Mutations in CHEK2 associated with prostate cancer riskQ37219438
Pathological features of colorectal carcinomas in MYH-associated polyposisQ37368316
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predispositionQ37542430
Jejunal cancer in patients with familial adenomatous polyposisQ37732936
Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteriaQ38153670
High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposisQ38855823
Familial cancer syndromes: A surveyQ39861086
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.Q40727923
CHEK2 I157T associates with familial and sporadic colorectal cancerQ43169381
Tamoxifen and risk of endometrial cancerQ43528467
Hereditary ovarian cancer in Poland.Q43683502
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the BahamasQ43702401
Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumorsQ43871566
Expanded extracolonic tumor spectrum in MUTYH-associated polyposisQ44674408
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectheritabilityQ1503548
P304page(s)1756-1763
P577publication date2014-06-19
P1433published inInternational Journal of CancerQ332492
P1476titleMultiple primary cancers as a guide to heritability
P478volume135

Reverse relations

cites work (P2860)
Q89654302A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results
Q43201507C57BL/6N Mice Are More Resistant to Ehrlich Ascites Tumors Than C57BL/6J Mice: The Role of Macrophage Nitric Oxide.
Q28396964Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s
Q37615396Germline large genomic alterations on 7q in patients with multiple primary cancers.
Q92059446Hereditary gastric cancer: Three rules to reduce missed diagnoses
Q92581632Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer
Q64974989Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer.
Q28389071Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
Q48288066Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families.
Q91705887Prostate cancer prognosis in men with other malignancies prior to radical prostatectomy
Q40378252Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
Q49560859Reply to 'Comment on 'Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system".
Q47653008Socioeconomic Status and Childhood Cancer Incidence: A Population-Based Multilevel Analysis
Q26785320Synchronous double primary gastric and endometrial cancer: a case report and literature review
Q92326922Synchronous multiple primary gastrointestinal cancers with CDH1 mutations: A case report
Q36183280Temporal trends in the risk of developing multiple primary cancers: a systematic review.